Alzheimer's Disease

Alzheon Inc. has announced positive interim findings from an ongoing phase 2 study evaluating ALZ-801, an investigational disease-modifying treatment for Alzheimer’s disease.

A device designed to improve cerebral blood flow was associated with improvements in mild cognitive impairment and Alzheimer’s disease, according to a presenter at the American College of Cardiology Scientific Session.

The Veterans’ Health Administration will provide coverage of a drug for the treatment of Alzheimer’s disease to veterans with early stages of the disease, according to a press release from the drug’s manufacturer.

With the increasing number of available treatments for Alzheimer’s disease, it is important for patients with cognitive concerns to openly communicate with their doctors, the Alzheimer’s Association said in a press release.

People who adhered more closely to the Mediterranean diet had a lower risk for dementia, regardless of genetic risk, according to data published in BMC Medicine.

A new blood test may be able to detect Alzheimer’s disease-related pathology up to 10 years before symptoms appear, according to a press release from Durin Technologies.

A noninvasive focused ultrasound technology was used in an FDA-approved clinical trial to treat Alzheimer’s disease, according to a press release.

Linus Health announced a collaboration with Goizueta Institute @Emory Brain Health and The Seavey Clinic at Emory Healthcare to implement digital cognitive assessments in primary care for early detection of Alzheimer’s disease.

Conceptualizing Alzheimer’s disease as an autoimmune disease of the brain rather than a brain disorder could change the way future treatments are developed, according to a recent paper published in Alzheimer’s & Dementia.

The plasma biomarker P-tau217 predicted cognitive decline in patients with preclinical Alzheimer’s disease and may complement cerebrospinal fluid and positron emission tomography as a patient-screening tool in clinical trials.